How to improve patient satisfaction during midazolam sedation for gastrointestinal endoscopy?

Table 6 Factors associated with sedation satisfaction in the combined esophagogastroduodenoscopy and colonoscopy group

	Univariate analysis				Multivariate analysis
	β	SE (β)	P value	OR (95% CI)	β	SE (β)	P value	OR (95%CI)
Sex (Female)	0.689	0.349	0.049	1.99 (1.00-3.95)
Age (> 50 yr)	-0.868	0.407	0.033	0.42 (0.19-0.93)	-0.978	0.427	0.022	0.38 (0.16-0.87)
Body mass index (kg/m2)	-0.001	0.006	0.878	1.00 (0.99-1.01)
Previous sedation endoscopy	-0.013	0.395	0.974	0.99 (0.46-2.14)
Midazolam, first dose (mg)	0.105	0.210	0.619	1.11 (0.74-1.68)
Midazolam, total dose (mg)	0.278	0.113	0.014	1.32 (1.06-1.65)
No. of midazolam injections	0.690	0.284	0.015	1.99 (1.14-3.48)
Time (min)
Midazolam injection to procedure start	0.041	0.033	0.215	1.04 (0.98-1.11)
Procedure time
Inter-procedure time gap	0.021	0.010	0.043	1.02 (1.00-1.04)	0.024	0.011	0.027	1.02 (1.00-1.05)
Colonoscopy insertion time	0.084	0.038	0.027	1.09 (1.01-1.17)
Colonoscopy withdrawal time	0.069	0.025	0.006	1.07 (1.02-1.13)	0.081	0.027	0.002	1.08 (1.03-1.14)
Procedure finish to antidote injection	0.014	0.029	0.637	1.01 (0.96-1.07)